InvestorsHub Logo
Followers 74
Posts 11224
Boards Moderated 2
Alias Born 02/13/2014

Re: rickstereo3333 post# 35080

Saturday, 03/18/2023 1:26:04 PM

Saturday, March 18, 2023 1:26:04 PM

Post# of 36559
Interesting

Didn’t RVVTF state this in November 2022?


“The FDA has now requested additional information, which would include clinical data, for them to agree on the Study’s revised endpoints. The Company plans to go over with the FDA the overall development plan for Bucillamine in COVID-19 and further review the Pre-Dose selection data that would support the appropriate endpoints.”

Are they going to provide the FDA with what they are looking for now?